Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORAL
2023-505483-11-00Phase 4Authorised
- Sponsor
- Aalborg University Hospital
- Start
- Jul 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 5
01
Overview
Phase 4, randomised, open-label trial of meropenem, cefotaxime, moxifloxacin, linezolid, clindamycin and 3 more in brain abscess (2 arms), sponsored by Aalborg University Hospital. Primary endpoint: Primary composite outcome. Planned start Jul 2023; status: authorised.
02
Drugs
meropenemcefotaximemoxifloxacinlinezolidclindamycin
03
Conditions
brain abscess
Beyond the preview
Go deeper on 2023-505483-11-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-505483-11-00.